CORE--KNOWLEDGE TRANSFER

核心——知识转移

• 批准号: 6315904
• 负责人: ALAN MENDELOWITZ
• 金额: $ 17.52万
• 依托单位: LONG ISLAND JEWISH MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2000
• 资助国家: 美国
• 起止时间: 2000-02-18 至 2005-01-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6315904
• 关键词: antipsychotic agents; behavioral /social science research tag; biomedical facility; clinical research; clozapine; disease /disorder prevention /control; drug adverse effect; early diagnosis; health care personnel education; health care service utilization; health education; human subject; information dissemination; mental disorder chemotherapy; mental disorder diagnosis; mental health services; method development; outcomes research; patient care management; schizophrenia

DESCRIPTION: The overall goal of this new Knowledge Transfer Unit (KTU) is to better inform the medical community, patients, and their families about schizophrenia. There are 4 aims of the KTU. First is to improve the recognition of prodromal and early signs of schizophrenia and stress the importance of early intervention. Second is to improve knowledge and utilization of best treatments for schizophrenia. Third is to improve knowledge about the size effects of anti-schizophrenia medications. Finally, the KTU aims to increase the knowledge concerning poor treatment response and the role of clozapine in the method of "academic detailing" seems to be a worthy intellectual centerpiece for this unit. The leaders of the KTU are both junior, and there are examples of issues that seem internalized.

描述：这个新的知识转移单元 (KTU) 的总体目标是更好地向医学界、患者及其家人宣传精神分裂症。 KTU 有 4 个目标。首先是提高对精神分裂症前驱症状和早期症状的认识，并强调早期干预的重要性。其次是提高对精神分裂症最佳治疗方法的了解和利用。第三是提高对抗精神分裂症药物的尺寸效应的了解。最后，KTU 旨在增加有关不良治疗反应的知识，以及氯氮平在“学术细节”方法中的作用似乎是该单元值得的知识中心。 KTU 的领导人都是资历浅的，而且有一些问题似乎是内部化的。